'J clin onc' diaporamas de présentation

799 views • 55 slides

Ph positive ALL; Is transplant still necessary? Adele K. Fielding MB BS, PhD

586 views • 48 slides

Learning Objectives A t the conclusion of this presentation participants should understand the following:

Use of pharmacogenetics in understanding patient susceptibility to 5-FU/capecitabine toxicity Toxicity risk associated with variations in DPYD and TYMS DPYD = DPD deficiency TYMS= TS deficiency Use of genetic test results in medical management.

569 views • 15 slides